GHRP-6 combined with dedicated healing peptides like BPC-157 and TB-500 creates a multi-pathway approach to recovery
That distinction matters clinically, but it does not change the fact that NAD+ therapy is one of the most evidence-backed interventions we use for energy, cellular repair, and cognitive performance at our clinic
Interaction with other medications: Glutathione is known to interfere with blood pressure medication so it is not advisable for those suffering from high blood pressure
Weeks 14: Improved sleep quality (often the first and most consistent effect) Enhanced recovery between training sessions Some users report mild water retention initially Weeks 48: Noticeable changes in body composition lean mass up, fat down (most pronounced in visceral and subcutaneous fat) Skin quality improvements (GH and IGF-1 drive collagen synthesis) Faster soft tissue recovery from training or injury Weeks 816: Sustained lean mass gains Fat loss continues, particularly around the abdomen Anti-aging markers: joint comfort, skin elasticity, energy levels Important calibration: GH peptides won't produce results like supraphysiological anabolic compounds
Seven peptides are on the July 23-24, 2026 agenda for section 503A review: BPC-157, KPV, TB-500, and MOTS-C on July 23, and Emideltide (DSIP), Semax, and Epitalon on July 24